|
HOXA2
(HGNC:5103)
|
microtia
(MONDO_0010920)
|
Moderate
|
|
|
HOXA1
(HGNC:5099)
|
Bosley-Salih-Alorainy syndrome
(MONDO_0019075)
|
Strong
|
|
|
HOXA1
(HGNC:5099)
|
human HOXA1 syndromes
(MONDO_0011099)
|
Moderate
|
|
|
HNRNPH2
(HGNC:5042)
|
intellectual disability, X-linked, syndromic, Bain type
(MONDO_0010512)
|
Strong
|
|
|
HNRNPH1
(HGNC:5041)
|
neurodevelopmental disorder
(MONDO_0700092)
|
Limited
|
|
|
HNRNPA2B1
(HGNC:5033)
|
amyotrophic lateral sclerosis
(MONDO_0004976)
|
Limited
|
|
|
HNRNPA1
(HGNC:5031)
|
amyotrophic lateral sclerosis
(MONDO_0004976)
|
Moderate
|
|
|
HNMT
(HGNC:5028)
|
intellectual disability, autosomal recessive 51
(MONDO_0014759)
|
Moderate
|
|
|
HNF4A
(HGNC:5024)
|
maturity-onset diabetes of the young
(MONDO_0018911)
|
Definitive
|
|
|
HNF4A
(HGNC:5024)
|
monogenic diabetes
(MONDO_0015967)
|
Definitive
|
|
|
HNF4A
(HGNC:5024)
|
maturity-onset diabetes of the young type 1
(MONDO_0007452)
|
Strong
|
|
|
HMX1
(HGNC:5017)
|
oculoauricular syndrome
(MONDO_0012802)
|
Moderate
|
|
|
HMOX1
(HGNC:5013)
|
heme oxygenase 1 deficiency
(MONDO_0013536)
|
Moderate
|
|
|
HMOX1
(HGNC:5013)
|
chronic obstructive pulmonary disease
(MONDO_0005002)
|
Disputed
|
|
|
HMGA1
(HGNC:5010)
|
type 2 diabetes mellitus
(MONDO_0005148)
|
Disputed
|
|
|
HMGCS2
(HGNC:5008)
|
3-hydroxy-3-methylglutaryl-CoA synthase deficiency
(MONDO_0011614)
|
Strong
|
|
|
HMGA2
(HGNC:5009)
|
Silver-Russell syndrome 5
(MONDO_0020795)
|
Moderate
|
|
|
MNX1
(HGNC:4979)
|
permanent neonatal diabetes mellitus
(MONDO_0100164)
|
Limited
|
|
|
MNX1
(HGNC:4979)
|
neonatal diabetes mellitus
(MONDO_0016391)
|
Limited
|
|
|
RIPK4
(HGNC:496)
|
ectodermal dysplasia syndrome
(MONDO_0019287)
|
Moderate
|
|